Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing transplantation procedures through identification of prognostic factors in second remission for children with acute myeloid leukemia with no prior history of transplant.
Ishida H, Tsujimoto SI, Hasegawa D, Sakaguchi H, Yamamoto S, Yanagimachi M, Koh K, Watanabe A, Hama A, Cho Y, Watanabe K, Noguchi M, Takeuchi M, Takita J, Washio K, Kato K, Koike T, Hashii Y, Tabuchi K, Hino M, Atsuta Y, Okamoto Y. Ishida H, et al. Among authors: cho y. Haematologica. 2024 Jan 1;109(1):312-317. doi: 10.3324/haematol.2023.283203. Haematologica. 2024. PMID: 37470138 Free PMC article. No abstract available.
Comparison of intravenous with oral busulfan in allogeneic hematopoietic stem cell transplantation with myeloablative conditioning regimens for pediatric acute leukemia.
Kato M, Takahashi Y, Tomizawa D, Okamoto Y, Inagaki J, Koh K, Ogawa A, Okada K, Cho Y, Takita J, Goto H, Sakamaki H, Yabe H, Kawa K, Suzuki R, Kudo K, Kato K. Kato M, et al. Among authors: cho y. Biol Blood Marrow Transplant. 2013 Dec;19(12):1690-4. doi: 10.1016/j.bbmt.2013.09.012. Epub 2013 Sep 23. Biol Blood Marrow Transplant. 2013. PMID: 24071595 Free article.
Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation.
Kato M, Ishida H, Koh K, Inagaki J, Kato K, Goto H, Kaneko T, Cho Y, Hashii Y, Kurosawa H, Takita J, Hamamoto K, Inoue M, Sawada A, Suzuki R, Kato K. Kato M, et al. Among authors: cho y. Pediatr Blood Cancer. 2015 Oct;62(10):1844-50. doi: 10.1002/pbc.25602. Epub 2015 Jun 5. Pediatr Blood Cancer. 2015. PMID: 26053959
Comparison of second transplantation and donor lymphocyte infusion for donor mixed chimerism after allogeneic stem cell transplantation for nonmalignant diseases.
Umeda K, Adachi S, Tanaka S, Miki M, Okada K, Hashii Y, Inoue M, Cho Y, Koh K, Goto H, Kajiwara R, Hyakuna N, Kato K, Morio T, Yabe H; Inherited Disease Working Group of the Japan Society for Hematopoietic Cell Transplantation. Umeda K, et al. Among authors: cho y. Pediatr Blood Cancer. 2016 Dec;63(12):2221-2229. doi: 10.1002/pbc.26141. Epub 2016 Aug 24. Pediatr Blood Cancer. 2016. PMID: 27554591
Comparison of Donor Sources in Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Nationwide Retrospective Study.
Sakaguchi H, Watanabe N, Matsumoto K, Yabe H, Kato S, Ogawa A, Inagaki J, Goto H, Koh K, Yoshida N, Kato K, Cho Y, Kosaka Y, Takahashi Y, Inoue M, Kato K, Atsuta Y, Miyamura K; Donor/Source Working Group of Japan Society of Hematopoietic Cell Transplantation. Sakaguchi H, et al. Among authors: cho y. Biol Blood Marrow Transplant. 2016 Dec;22(12):2226-2234. doi: 10.1016/j.bbmt.2016.09.020. Epub 2016 Sep 22. Biol Blood Marrow Transplant. 2016. PMID: 27667011 Free article.
Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.
Kato M, Kurata M, Kanda J, Kato K, Tomizawa D, Kudo K, Yoshida N, Watanabe K, Shimada H, Inagaki J, Koh K, Goto H, Kato K, Cho Y, Yuza Y, Ogawa A, Okada K, Inoue M, Hashii Y, Teshima T, Murata M, Atsuta Y. Kato M, et al. Among authors: cho y. Bone Marrow Transplant. 2019 Jan;54(1):68-75. doi: 10.1038/s41409-018-0221-6. Epub 2018 May 24. Bone Marrow Transplant. 2019. PMID: 29795428 Clinical Trial.
Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.
Tomizawa D, Yoshida M, Kondo T, Miyamura T, Taga T, Adachi S, Koh K, Noguchi M, Kakuda H, Watanabe K, Cho Y, Fukuda T, Kato M, Shiba N, Goto H, Okada K, Inoue M, Hashii Y, Atsuta Y, Ishida H. Tomizawa D, et al. Among authors: cho y. Bone Marrow Transplant. 2019 Mar;54(3):393-401. doi: 10.1038/s41409-018-0273-7. Epub 2018 Jun 29. Bone Marrow Transplant. 2019. PMID: 29959436
Long-term outcome and chimerism in patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation: a retrospective nationwide survey.
Iguchi A, Cho Y, Yabe H, Kato S, Kato K, Hara J, Koh K, Takita J, Ishihara T, Inoue M, Imai K, Nakayama H, Hashii Y, Morimoto A, Atsuta Y, Morio T; Hereditary disorder Working Group of the Japan Society for Hematopoietic Cell Transplantation. Iguchi A, et al. Among authors: cho y. Int J Hematol. 2019 Sep;110(3):364-369. doi: 10.1007/s12185-019-02686-y. Epub 2019 Jun 11. Int J Hematol. 2019. PMID: 31187438 Clinical Trial.
15,279 results
You have reached the last available page of results. Please see the User Guide for more information.